Solara Active Pharma Reports Q2 Profit Turnaround and Revenue Growth in FY27
Solara Active Pharma Sciences reported a significant turnaround in Q2FY27 with a consolidated net profit of around ₹28.5 crore, reversing a loss from the previous year. Revenue rose approximately 33% year-on-year to over ₹417 crore for the quarter. For the half-year, net profit surged over 100-fold to about ₹44.7 crore, supported by increased revenue and despite an exceptional loss related to the Vizag plant. The company’s share price rose over 16%, nearing its 52-week high amid positive market response.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (72/100). Lens Score 40/100.
Outlets measured: businessstandard, freepressjournal. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (68–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
freepressjournal broke this story on 16 Oct, 08:16 am. Other outlets followed.